OR21-1 The PaTH Forward Trial: Efficacy and Safety of TransCon PTH Through Week 84 for Adults With Hypoparathyroidism

BACKGROUND: Hypoparathyroidism is a rare disease characterized by deficiency of parathyroid hormone (PTH), resulting in abnormal mineral homeostasis. Conventional therapy (active vitamin D and calcium) targets short-term symptoms, but fails to restore normal PTH physiology, and may lead to complicat...

Descripción completa

Detalles Bibliográficos
Autores principales: Ahmed, Intekhab, Eriksen, Erik, Hofbauer, Lorenz, Khan, Aliya, Le, John, Marcocci, Claudio, Markova, Denka, Pagotto, Uberto, Palermo, Andrea, Pihl, Susanne, Rejnmark, Lars, Schwarz, Peter, Shu, Aimee, Sibley, Christopher, Vansaghi, Lisa, Vokes, Tamara, Clarke, Bart
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2022
Materias:
Bone & Mineral Metabolism
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625017/
http://dx.doi.org/10.1210/jendso/bvac150.398

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9625017/
http://dx.doi.org/10.1210/jendso/bvac150.398

Ejemplares similares